HOSPITAL UNIVERSITARIO RUBER

Department

Foto de HOSPITAL UNIVERSITARIO RUBER

Foto de Institute of Oncology Ljubljana

Institute of Oncology Ljubljana

Liubliana, Eslovenia

Publications in collaboration with researchers from Institute of Oncology Ljubljana (3)

2020

Trastuzumab emtansine plus non-pegylated liposomal doxorubicin in HER2-positive metastatic breast cancer (Thelma): A single-arm, multicenter, phase Ib trial
Cancers, Vol. 12, Núm. 12, pp. 1-14

2018

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: Final results of the IBCSG 42-12/BIG 2-12 SNAP trial
Annals of Oncology, Vol. 29, Núm. 3, pp. 661-668

2016

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366